Maxime Pesant is Investment Manager for the life science group at the Fonds de Solidarité FTQ. He is involved in several preclinical and clinical-stage life science companies as well as in many venture capital funds. Prior to joining the Fonds, he was Partner & CFO at AmorChem, a Montreal-based life science seed fund, where he was responsible for all financial matters and administration. He also acted as part-time CFO for Nuchem Therapeutics, a medicinal chemistry service company, from its inception to its successful management buyout in 2018. He is active in the venture capital industry, namely through its participation in Réseau Capital Program’s Committee and previously as the founder of the New Generation Committee.
Maxime holds a CPA, CMA designation from the Ordre des Comptables professionnels agréés du Québec (Quebec CPA Order) and a CFA designation from the CFA Institute.